NASDAQ:PLSE - Pulse Biosciences Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$15.25 -1.27 (-7.69 %)
(As of 06/25/2018 11:37 AM ET)
Previous Close$16.13
Today's Range$15.25 - $16.13
52-Week Range$9.81 - $37.50
Volume364 shs
Average Volume67,743 shs
Market Capitalization$278.81 million
P/E RatioN/A
Dividend YieldN/A
Beta1.89
Pulse Biosciences logoPulse Biosciences, Inc., a clinical-stage medical technology company, develops therapeutic tissue treatment platform based on its proprietary nano-pulse stimulation (NPS) technology. Its NPS is a non-thermal, precise, and focal drug-free tissue treatment technology that initiates cell death within treated tissue used in oncology, dermatology/aesthetics, minimally invasive, and veterinary applications. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was founded in 2014 and is headquartered in Hayward, California.

Receive PLSE News and Ratings via Email

Sign-up to receive the latest news and ratings for PLSE and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:PLSE
CUSIPN/A
Phone510-906-4600

Debt

Debt-to-Equity RatioN/A
Current Ratio15.41
Quick Ratio15.41

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book Value$2.81 per share
Price / Book5.43

Profitability

EPS (Most Recent Fiscal Year)N/A
Net Income$-25,560,000.00
Net MarginsN/A
Return on Equity-77.03%
Return on Assets-70.27%

Miscellaneous

Employees33
Outstanding Shares16,880,000

The Truth About Cryptocurrencies

Pulse Biosciences (NASDAQ:PLSE) Frequently Asked Questions

What is Pulse Biosciences' stock symbol?

Pulse Biosciences trades on the NASDAQ under the ticker symbol "PLSE."

How were Pulse Biosciences' earnings last quarter?

Pulse Biosciences Inc (NASDAQ:PLSE) issued its quarterly earnings data on Tuesday, May, 8th. The company reported ($0.51) earnings per share for the quarter. View Pulse Biosciences' Earnings History.

Who are some of Pulse Biosciences' key competitors?

Who are Pulse Biosciences' key executives?

Pulse Biosciences' management team includes the folowing people:
  • Mr. Darrin R. Uecker, Pres, CEO & Director (Age 52)
  • Mr. Brian B. Dow, CFO, Sr. VP of Fin. & Admin., Treasurer and Sec. (Age 49)
  • Dr. Richard Nuccitelli Ph.D., Chief Science Officer
  • Dr. Holly Hartman Ph.D., J.D., VP of Bus. Devel. & Corp. Strategy
  • Mr. David Danitz, VP of Engineering

When did Pulse Biosciences IPO?

(PLSE) raised $20 million in an IPO on Wednesday, May 18th 2016. The company issued 5,000,000 shares at $4.00 per share. MDB Capital Group and Feltl and Company served as the underwriters for the IPO.

Has Pulse Biosciences been receiving favorable news coverage?

Headlines about PLSE stock have been trending somewhat positive this week, Accern Sentiment Analysis reports. The research firm identifies negative and positive media coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Pulse Biosciences earned a news impact score of 0.16 on Accern's scale. They also gave headlines about the company an impact score of 45.82 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock's share price in the near term.

Who are Pulse Biosciences' major shareholders?

Pulse Biosciences' stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (2.89%), Northern Trust Corp (0.55%) and Citadel Advisors LLC (0.19%). Company insiders that own Pulse Biosciences stock include Maky Zanganeh, Mitchell E Levinson, Robert J Greenberg, Robert W Duggan and Thierry B Thaure. View Institutional Ownership Trends for Pulse Biosciences.

Which institutional investors are selling Pulse Biosciences stock?

PLSE stock was sold by a variety of institutional investors in the last quarter, including Citadel Advisors LLC, BlackRock Inc. and Northern Trust Corp. View Insider Buying and Selling for Pulse Biosciences.

How do I buy shares of Pulse Biosciences?

Shares of PLSE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Pulse Biosciences' stock price today?

One share of PLSE stock can currently be purchased for approximately $15.25.

How big of a company is Pulse Biosciences?

Pulse Biosciences has a market capitalization of $278.81 million. Pulse Biosciences employs 33 workers across the globe.

How can I contact Pulse Biosciences?

Pulse Biosciences' mailing address is 3957 POINT EDEN WAY, HAYWARD CA, 94545. The company can be reached via phone at 510-906-4600 or via email at [email protected]


MarketBeat Community Rating for Pulse Biosciences (PLSE)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  117 (Vote Outperform)
Underperform Votes:  120 (Vote Underperform)
Total Votes:  237
MarketBeat's community ratings are surveys of what our community members think about Pulse Biosciences and other stocks. Vote "Outperform" if you believe PLSE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PLSE will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/25/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.